Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.27 USD
−60.64 M USD
84.51 M USD
21.92 M
About Fortress Biotech, Inc.
Sector
CEO
Lindsay Allan Rosenwald
Headquarters
Bay Harbor Islands
Website
Founded
2006
FIGI
BBG001J2MFH6
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FBIO is 1.61 USD — it has increased by 2.55% in the past 24 hours. Watch Fortress Biotech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fortress Biotech, Inc. stocks are traded under the ticker FBIO.
FBIO stock has risen by 3.87% compared to the previous week, the month change is a −11.05% fall, over the last year Fortress Biotech, Inc. has showed a −27.48% decrease.
We've gathered analysts' opinions on Fortress Biotech, Inc. future price: according to them, FBIO price has a max estimate of 26.00 USD and a min estimate of 4.00 USD. Watch FBIO chart and read a more detailed Fortress Biotech, Inc. stock forecast: see what analysts think of Fortress Biotech, Inc. and suggest that you do with its stocks.
FBIO reached its all-time high on Apr 23, 2013 with the price of 190.40 USD, and its all-time low was 1.24 USD and was reached on Nov 10, 2023. View more price dynamics on FBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FBIO stock is 4.52% volatile and has beta coefficient of 1.24. Track Fortress Biotech, Inc. stock price on the chart and check out the list of the most volatile stocks — is Fortress Biotech, Inc. there?
Today Fortress Biotech, Inc. has the market capitalization of 44.44 M, it has increased by 9.79% over the last week.
Yes, you can track Fortress Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
Fortress Biotech, Inc. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
FBIO earnings for the last quarter are −0.76 USD per share, whereas the estimation was −0.59 USD resulting in a −27.73% surprise. The estimated earnings for the next quarter are −0.75 USD per share. See more details about Fortress Biotech, Inc. earnings.
Fortress Biotech, Inc. revenue for the last quarter amounts to 14.63 M USD, despite the estimated figure of 32.22 M USD. In the next quarter, revenue is expected to reach 16.30 M USD.
FBIO net income for the last quarter is −12.87 M USD, while the quarter before that showed −10.95 M USD of net income which accounts for −17.53% change. Track more Fortress Biotech, Inc. financial stats to get the full picture.
No, FBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 186.00 employees. See our rating of the largest employees — is Fortress Biotech, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fortress Biotech, Inc. EBITDA is −96.09 M USD, and current EBITDA margin is −155.20%. See more stats in Fortress Biotech, Inc. financial statements.
Like other stocks, FBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fortress Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fortress Biotech, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fortress Biotech, Inc. stock shows the sell signal. See more of Fortress Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.